Concepedia

Kristen M. Jacobsen

KM

Statistics

Publications

11

Citations

829

H-Index

11

Active since

2008

Affiliations

University of Colorado Denver(Current)

University of North Carolina at Chapel Hill

Emory University

Science Applications International Corporation (United States)

University of Colorado Anschutz Medical Campus

Kristen M. Jacobsen is an author at University of Colorado Denver specializing in oncology, tyrosine kinase inhibitors, and cell signaling.

Publications per year

2008–2022

11

Publications

11

Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis

Elizabeth F. Redente, Kristen M. Jacobsen, Joshua J. Solomon et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2011 · 217 citations · Full text

, , +17

MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis

Rebecca S. Cook, Kristen M. Jacobsen, Anne Wofford et al. · Journal of Clinical Investigation · 2013 · 183 citations · Full text

, , +17

UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models

Deborah DeRyckere, Alisa B. Lee‐Sherick, Madeline G. Huey et al. · Clinical Cancer Research · 2016 · 73 citations · Full text

, , +16

MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity

Alisa B. Lee‐Sherick, Kristen M. Jacobsen, Curtis J. Henry et al. · JCI Insight · 2018 · 73 citations · Full text

, , +17

Bortezomib Sensitizes Human Renal Cell Carcinomas to TRAIL Apoptosis through Increased Activation of Caspase-8 in the Death-Inducing Signaling Complex

Alan D. Brooks, Kristen M. Jacobsen, Wenqing Li et al. · Molecular Cancer Research · 2010 · 69 citations · Full text

, , +17

1–5 of 11